Clinical Trials
47 trialsTRIDENT-1
Turning Point Therapeutics, Inc.
Diagnosis of Pheochromocytoma
National Institutes of Health Clinical Center (CC)
LIBRETTO-001
Eli Lilly and Company
MUSE-OVARY
Healing Hope International
Late Endocrine and Metabolic Consequences After Childhood Brain Tumor Treatment
Institute of Oncology Ljubljana
SOPK
University Hospital, Strasbourg, France
LIBRETTO-121
Eli Lilly and Company
Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China
Huazhong University of Science and Technology
Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy
University of Michigan
ARROW
Hoffmann-La Roche
Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca
Thomas Jefferson University
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Zhujiang Hospital
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
The First Affiliated Hospital with Nanjing Medical University
Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models
IRCCS San Raffaele
OSPREY
OncoSil Medical Limited
A BHI to Increase Hope Level and Stress Level of Parents With a CMC
The Hong Kong Polytechnic University
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Corcept Therapeutics
Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer
St. James's Hospital, Ireland
CanStem111P
Sumitomo Pharma America, Inc.
DIMOXIS
Royal College of Surgeons, Ireland
PEP-Colombia
Instituto de fertilidad humana, InSer
apact
Celgene
Evaluation of Women With Endocrine and Reproductive-Related Conditions
National Institutes of Health Clinical Center (CC)
Dietary Patterns and Health Outcomes (Cardiovascular, Metabolic, Endocrine, Neurological, Skeletal Muscular, Cancer)
Harvard School of Public Health (HSPH)
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma
Catalysis SL
SEPTRALU
Sociedad Española de Medicina Nuclear e Imagen Molecular
Research on the Application and Mechanism of New Biological Probes in Biomedicine
Nanfang Hospital, Southern Medical University
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer
Catalysis SL
AVANIRA3
Jiangsu Cancer Institute & Hospital
IOTA-MRI
KU Leuven
IOTA7
KU Leuven
CHIMeRA
Groupe Hospitalier Pitie-Salpetriere
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers
Belgian Gynaecological Oncology Group
Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients
St. Jude Children's Research Hospital
Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment
University of Iowa
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
University of Pittsburgh
A Study of AZD4901 in Females With Polycystic Ovary Syndrome
AstraZeneca
NET
Assistance Publique - Hôpitaux de Paris
One Week Comparison Study of PTH and PTHrP Infusions
University of Pittsburgh
A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)
Tesaro, Inc.
REPOS
University of Nottingham
REPOS
University of Nottingham
Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary Syndrome
Royan Institute
Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
Office of Rare Diseases (ORD)
Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome
National Center for Research Resources (NCRR)
Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome
Office of Rare Diseases (ORD)